Cost of Illness Analysis of Insulin and Insulin-Metformin Combination Usage towards Diabetes Mellitus Type 2 Patients at Hospital in Bandung

Sholih, Mally Ghinan; Muhtadi, ‪Ahmad; Saidah, Siti

doi:10.15416/ijcp.2018.7.1.10

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Beberapa Penelitian mengenai diabetes mellitus menyatakan bahwa kualitas hidup penderita diabetes mellitus dipengaruhi beberapa faktor diantaranya jenis kelamin, tingkat pendidikan, status sosial ekonomi, status pernikahan, faktor medis, dan faktor psikologis yaitu kecemasan [4]. Konsumsi makanan yang meningkat serta gaya hidup merupakan faktor penghambat dalam pencapaian target terapi diabetes mellitus [5]. Tujuan terapi diabetes mellitus yakni untuk mencapai nilai atau kadar glukosa normal dalam tubuh tanpa adanya hipoglikemia serta mampu memelihara kualitas hidup yang baik.…”

Section: A Pendahuluanunclassified

Cost of Illness Pasien Diabetes Mellitus Tipe 2 JKN Non Pbi Di Instalasi Rawat Inap Rumah Sakit Islam Sultan Agung Semarang Periode Januari-Desember 2022

Hamidah,

Advistasari,

Sari

2023

JIPP

View full text Add to dashboard Cite

show abstract

Section: A Pendahuluanunclassified

Cost of Illness Pasien Diabetes Mellitus Tipe 2 JKN Non Pbi Di Instalasi Rawat Inap Rumah Sakit Islam Sultan Agung Semarang Periode Januari-Desember 2022

Hamidah,

Advistasari,

Sari

2023

JIPP

View full text Add to dashboard Cite

show abstract

Cost of illness of diabetes mellitus in Indonesia: a systematic review

Patty

Mufarrihah

Nita

2021

Journal of Basic and Clinical Physiology and Pharmacology

View full text Add to dashboard Cite

Objectives Diabetes Mellitus (DM) is a group of insulin metabolism disorder that affects the socio-economic conditions of the community. The cost of treating diabetes in 2019 was USD 760 billion and by 2045 there are predicted to be 700 million people living with diabetes. The purpose of this systematic review was to provide an overview of the economic burden caused by Diabetes Mellitus for the government, health care providers, and for the community. Methods This systematic review was carried out by considering the related studies about the cost of illness, evaluation of disease costs, or therapeutic costs for various types of diabetes mellitus that were published in both English and Indonesian. The search engines PUBMED, DOAJ, SCOPUS, SCIENCE DIRECT, and GOOGLE SCHOLAR were used without date published restrictions. Results A systematic search identifies 18 eligible studies conducted in various regions in Indonesia. The study was retrospective with variation in their perspectives and methods to estimate the diabetes cost. Drug cost was the major contributor to direct medical cost followed by complications cost while other cost was affected by transportation cost, productivity losses, and time spent by family accompanying patients. Conclusions Diabetes mellitus creates a significant financial burden and affects the health care system as well as the individual and society as a whole. Research about the cost of diabetes in the future should be carried out on a large scale in order to get a more specific cost estimation.

show abstract

Cost of Illness Analysis of Insulin and Insulin-Metformin Combination Usage towards Diabetes Mellitus Type 2 Patients at Hospital in Bandung

Cited by 2 publications

References 0 publications

Cost of Illness Pasien Diabetes Mellitus Tipe 2 JKN Non Pbi Di Instalasi Rawat Inap Rumah Sakit Islam Sultan Agung Semarang Periode Januari-Desember 2022

Cost of Illness Pasien Diabetes Mellitus Tipe 2 JKN Non Pbi Di Instalasi Rawat Inap Rumah Sakit Islam Sultan Agung Semarang Periode Januari-Desember 2022

Cost of illness of diabetes mellitus in Indonesia: a systematic review

Contact Info

Product

Resources

About